Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
71 Leser
Artikel bewerten:
(0)

China Nepstar Chain Drugstore Filed 2012 Annual Report on Form 20-F

SHENZHEN, China, April 26, 2013 /PRNewswire/- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced the Company filed its annual report on Form 20-F for the year ended December 31, 2012 with the Securities and Exchange Commission on April 26, 2013. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2012, free of charge, to its shareholders and ADS holders upon request.

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd.(NYSE: NPD) isChina's largest retail drugstore chain based on the number of directly operated stores. As ofDecember 31, 2012, the Company had 2,132 stores across 73 cities, one headquarter distribution center and 16 regional distribution centers inChina. Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the continuing economic growth inChinaand to take advantage of the demographic trend inChinato achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn.

Contacts

Zixin Shao
China Nepstar Chain Drugstore Ltd.
Chief Financial Officer
+86-755-2641-4065
ir@nepstar.cn

Dixon Chen
Grayling
Investor Relations
+1-646-284-9403
dixon.chen@grayling.com

Ivette Almeida
Grayling
Media Relations
+1-646-284-9455
ivette.almeida@grayling.com

SOURCE China Nepstar Chain Drugstore Ltd.

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.